Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria.
about
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administrationPre-referral rectal artesunate for severe malariaPharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationArtemisinins: their growing importance in medicinePopulation pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patientsIntramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled TrialMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy numberPopulation pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New GuineaArtemisinins.From bright ideas to tools: the case of malariaPrevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New GuineaThe pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malariaTherapy of falciparum malaria in sub-saharan Africa: from molecule to policy.Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations.Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial.Frequencies of Cytochrome P450 2B6 and 2C8 Allelic Variants in the Mozambican Population.Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.Dose-dependent resorption of quinine after intrarectal administration to children with moderate Plasmodium falciparum malaria.Toxicity of the antimalarial artemisinin and its dervatives.The pharmacokinetic evaluation of artemisinin drugs for the treatment of malaria in paediatric populations.Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria.Focus: malaria.Pharmacokinetics of artesunate following oral and rectal administration in healthy Sudanese volunteers.Treating severe malaria.
P2860
Q21034080-92E34914-475B-451B-B23F-3039C93663D8Q24194527-91340B26-C2C5-497E-8B80-3C03B992CAA9Q26830528-2227F385-6206-4DAC-BFE9-5578CE9B53D3Q27489880-CDCB4003-CDC5-4601-8D8D-253549CBB046Q28469076-5AED1264-747F-478C-9150-03F48CF70AEAQ28552379-BA27F0E4-2915-40A3-AD9B-D6A40E935C89Q29615128-CBC90A70-1DB2-4259-A258-2E1F6C415404Q30867699-50A8A5EE-6B5E-49AF-B21A-23F57D5D87C5Q31150958-ED929E1A-D370-4E0D-8565-6D0A637E623EQ33958541-F9016CD4-9575-406C-8BF4-7498334BBDE0Q34252476-8618F6EE-18A8-4F9B-B213-180B55F56E8EQ34509744-9752EBE4-D703-4722-BE37-66B478D7C544Q35521094-1C3D894E-B5EE-45B3-87AD-4A35AC954ABAQ35540103-B9792479-C27C-4CFA-A72E-AEAD51A0C637Q35669950-4F750D50-D669-4BD4-8D3F-DE67945C02EDQ35804378-B47C1052-CD5B-4420-90A9-6BBA2B3FD040Q35838600-699F22A4-C656-4734-9C62-ED50E28F2CFFQ36669256-8496EB98-AADF-486E-ACAA-4E5D7B0FF1CCQ36959519-D96544D5-07F6-47D7-BAEC-9CC67D05D02CQ37105545-4D0EF6C1-644D-416B-8416-8DFCAB324470Q37171678-95F9F41B-7314-4F67-8167-156A81355CFBQ37278622-6AEC8E5B-5616-4F47-BF64-68CAB4C1CABBQ37598674-2574925B-E0DC-4B02-B148-2748D2593CDAQ37693152-3C83194E-5399-488A-9707-F64348891CFCQ37841602-3764FE19-D81A-41FE-A27A-C7285D714DB3Q39468706-E80FD4CD-2E66-4A0E-BD41-FFEFF0070FACQ39603178-AC896F49-4AA1-4998-BF42-3C7D8BC79ED7Q42631890-2C638E94-98EA-475D-AED3-AB85B0196AB7Q42821400-A6FB90DE-0182-4991-9F1A-0ED27C274881
P2860
Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bioavailability and preliminar ...... hildren with moderate malaria.
@ast
Bioavailability and preliminar ...... hildren with moderate malaria.
@en
type
label
Bioavailability and preliminar ...... hildren with moderate malaria.
@ast
Bioavailability and preliminar ...... hildren with moderate malaria.
@en
prefLabel
Bioavailability and preliminar ...... hildren with moderate malaria.
@ast
Bioavailability and preliminar ...... hildren with moderate malaria.
@en
P2093
P2860
P1476
Bioavailability and preliminar ...... hildren with moderate malaria.
@en
P2093
A K Owusu-Ofori
D Agranoff
G Bedu-Addo
J A Appiah
S M Mansor
S Ramanathan
T Agbenyega
V Navaratnam
P2860
P304
P356
10.1128/AAC.45.2.509-516.2001
P407
P577
2001-02-01T00:00:00Z